These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12738732)

  • 1. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
    Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
    Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
    Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
    Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma.
    Takemasa I; Yamamoto H; Sekimoto M; Ohue M; Noura S; Miyake Y; Matsumoto T; Aihara T; Tomita N; Tamaki Y; Sakita I; Kikkawa N; Matsuura N; Shiozaki H; Monden M
    Cancer Res; 2000 Jun; 60(11):3043-50. PubMed ID: 10850455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CDC25A and CDC25B phosphatase proteins in human retinoblastoma and its correlation with clinicopathological parameters.
    Singh L; Pushker N; Sen S; Singh MK; Bakhshi S; Chawla B; Kashyap S
    Br J Ophthalmol; 2015 Apr; 99(4):457-63. PubMed ID: 25326518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
    Wu W; Fan YH; Kemp BL; Walsh G; Mao L
    Cancer Res; 1998 Sep; 58(18):4082-5. PubMed ID: 9751615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.
    Wang Z; Trope CG; Flørenes VA; Suo Z; Nesland JM; Holm R
    BMC Cancer; 2010 May; 10():233. PubMed ID: 20500813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CDC25A and CDC25B in head and neck cancers.
    Gasparotto D; Maestro R; Piccinin S; Vukosavljevic T; Barzan L; Sulfaro S; Boiocchi M
    Cancer Res; 1997 Jun; 57(12):2366-8. PubMed ID: 9192810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
    Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
    Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, meta-analysis and cross-species comparison.
    Lu X; Sun W; Tang Y; Zhu L; Li Y; Ou C; Yang C; Su J; Luo C; Hu Y; Cao J
    Mol Med Rep; 2016 Feb; 13(2):1172-8. PubMed ID: 26647881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of CDC25B expression in gliomas.
    Nakabayashi H; Hara M; Shimizu K
    J Clin Pathol; 2006 Jul; 59(7):725-8. PubMed ID: 16803948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
    Xu X; Yamamoto H; Liu G; Ito Y; Ngan CY; Kondo M; Nagano H; Dono K; Sekimoto M; Monden M
    Int J Mol Med; 2008 Feb; 21(2):145-52. PubMed ID: 18204780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients.
    Broggini M; Buraggi G; Brenna A; Riva L; Codegoni AM; Torri V; Lissoni AA; Mangioni C; D'Incalci M
    Anticancer Res; 2000; 20(6C):4835-40. PubMed ID: 11205229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cdc25B and cdc25A in medullary thyroid carcinoma: cdc25B expression level predicts a poor prognosis.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Nakamura Y; Kakudo K; Miyauchi A
    Cancer Lett; 2005 Nov; 229(2):291-7. PubMed ID: 16095809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
    Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
    Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas.
    Kudo Y; Yasui W; Ue T; Yamamoto S; Yokozaki H; Nikai H; Tahara E
    Jpn J Cancer Res; 1997 Oct; 88(10):947-52. PubMed ID: 9414655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.
    Hernández S; Hernández L; Beà S; Cazorla M; Fernández PL; Nadal A; Muntané J; Mallofré C; Montserrat E; Cardesa A; Campo E
    Cancer Res; 1998 Apr; 58(8):1762-7. PubMed ID: 9563496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
    Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and significance of CDC25B, PED/PEA-15 in esophageal carcinoma.
    Wang M; Zhu XY; Wang L; Lin Y
    Cancer Biother Radiopharm; 2015 Apr; 30(3):139-45. PubMed ID: 25775393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.